The effects of lithium on ex vivo cytokine production

Biological Psychiatry

Volumn 50, Issue 3, 2001, Pages 217-224

  Rapaport, Mark Hyman ^a,b,d   Manji, Husseini K ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclic AMP; Cytokines; IL 2; Immunology; Lithium; Myo inositol

Indexed keywords

CYCLIC AMP; GAMMA INTERFERON; INOSITOL; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LITHIUM; MITOGENIC AGENT; PHOSPHATIDYLINOSITIDE; PROSTAGLANDIN E2; PROTEIN KINASE C;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXPOSURE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOMODULATION; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND MESSENGER; TH1 CELL; TH2 CELL; TIME;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CELLS, CULTURED; CYCLIC AMP; CYTOKINES; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES;

EID: 0035422071     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01144-1     Document Type: Article

References (62)

1. Reduced brain inositol in lithium-treated rats
2. An alternative mechanism of glucocorticoid anti-proliferative effect: Promotion of a Th2 cytokine-secreting profile
3. Emergent properties of networks of biological signaling pathways
4. Molecular machines integrate coincident synaptic signals
5. Immunomodulatory effects of pharmacological elevation of cyclic AMP in T lymphocytes proceed via a protein kinase A independent mechanism
6. The effect of lithium chloride treatment on cell-mediated immunity in mice
7. Protective effect of lithium on the stress-induced depression of cell-mediated immunity in mice
8. Mechanisms of action of lithium in affective illness: Basic and clinical implications
9. 2 down-regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis
10. Interaction of lithium with vasopressin-sensitive cyclic AMP system of human renal medulla
11. Effect of lithium in vitro and after chronic treatment on human platelet adenylate cyclase activity: Postreceptor modification of second messenger signal amplification
12. Inositol lipids and signal transduction in the nervous system: An update
13. Effect of lithium in immunodeficiency: Improved blood cell formation in mice with decreased hematopoiesis as the result of LP-BM5 MuL V infection
14. Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride
15. Lithium treatment of MRL-Ipr mice alters disease progression in this murine model of systemic lupus erthematosus
16. Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass
17. 2 critically depends on interleukin-2*
18. "Crosswalk": A pivotal role for protein kinase C in modulating relationships between signal transduction pathways
19. Regulation of neurotransmitter receptor desensitization by protein phosphorylation
20. Anti-bipolar therapy: Mechanism of action of lithium
21. Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin
22. Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression
23. LiCl prolongs survival and alters disease progression in the NZB/W model of systemic lupus erythematosus
24. Modulation of cell-mediated immunity by lithium chloride
25. Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus
26. Lithium
27. Lithium chloride enhances survival of NZB/W lupus mice: Influence of melatonin and timing of treatment
28. Low dose LiCl treatment enhances survival and inhibits pancreatic beta cell destruction in the NOD model of type I diabetes
29. Lithium and immune function
30. Evidence for an immune response in major depression: A review and hypothesis
31. The acute phase protein response in schizophrenia, mania and manor depression: Effects of psychotropic drugs
32. In vitro immunoregulatory effects of lithium in healthy volunteers
33. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: Therapeutic implications
34. Regulation of PKC isozymes and substrates by lithium: The role of myo-inositol
35. Lithium dramatically decreases membrane-associated PKC in the hippocampus: Selectivity for the alpha isozyme
36. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of bipolar disorder
37. Signal transduction pathways: Molecular targets for lithium's actions
38. Effects of lithium carbonate on cytokine production in patients affected by breast cancer
39. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system
40. The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms
41. Investigations of the cellular immunity during depression and the free interval: Evidence for an immune activations in affective psychosis
42. T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation
43. Effect of lithium therapy on inflammatory response
44. Immune parameters in rapid cycling bipolar patients before and after lithium treatment
45. The effects of prolonged lithium exposure on the immune system of normal control subjects: Serial serum soluble interleukin-2 receptor and antithyroid antibody measurements
46. The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects
47. The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release
48. Signal sorting and amplification through G protein-coupled receptors
49. Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells
50. Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression
51. Protein kinase C
52. Tyrosine phosphorylation is an obligatory event in IL-2 secretion
53. The effect of short-term treatment with lithium and carbamazepine on some immunological indices in depressed patients
54. In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex
55. The role of G proteins in transmembrane signaling
56. Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells
57. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: Potentiation by muscarinic receptor activation
58. The "in vitro" effects of lithium on the immune system
59. Influence of Li on disease progression in murine models of diabetes: Differences between NOD and obese mice